logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
P

Prostate

IF2.5
Papers256
Citations7342
Journal Papers 225
Publication Date
delete
Circulating Tumor Cell Synaptophysin and Androgen Receptor Expression Reflect Prostate Cancer Phenotypes in Metastatic Disease
deleteProstate
IF2.5
delete2026-10-12
delete0
deleteOAAI
deleteEthan Lo; Alisa Clein; Michael Tam; Sara Trimble; Michael Hardin; Arturo Ramirez; Eric Kaldjian; Evan Y. Yu; Heather H. Cheng; Todd A. Yezefski; Andrew C. Hsieh; Petros Grivas; Bruce Montgomery; Peter S. Nelson; Michael T. Schweizer; Daniel E. Sabath; Steven Blinka
deleteShare
deleteSave
Exploratory Analysis of Peri‐Prostatic Adipose Tissue Radiomics Features and Their Potential to Predict Prostate Cancer Diagnosis: Results From a UK Biobank Study
deleteProstate
IF2.5
delete2026-10-08
delete0
PREAI
deleteAngela O'Neill; Ryan O'Keeffe; Sarah Winter; Jade Dorrian; Tom R. Gaunt; Vilmundur Guönason; Ruth C. Travis; Richard M. Martin; Emma H. Allott; Michelle Leech
deleteShare
deleteSave
Urinary Soluble Collagen Levels Are Associated With Moderate/Severe LUTS
deleteProstate
IF2.5
delete2026-10-07
delete0
deleteOAAI
deleteMarissa Sarna-McCarthy; Claweens Quetant; Quentin D'Arcy; Richard Caesar; Kourosh Zarringhalam; Jill A. Macoska
deleteShare
deleteSave
Human Prostate Cell Lines: Derivation, Molecular Characteristics and Appropriate Use
deleteProstate
IF2.5
delete2026-10-07
delete0
deleteOAAI
deleteHamza Abohamra; Keenau Mark Pearce
deleteShare
deleteSave
Defining ‘Freehand’ by Needle Control, Not Probe Stabilization: A Response to the Proposal of a Stepper-Stabilized Category
deleteProstate
IF2.5
delete2026-10-07
delete0
PREAI
deletePedro Ivo C. Ravizzini; Luis Silva; Victor Arthur G. Valdo; Daniel A. Rangel; Roni C. Fernandes
deleteShare
deleteSave
Stage-Specific Racial Disparities in Prostate Cancer Survival Outcomes
deleteProstate
IF2.5
delete2026-10-07
delete0
deleteOAAI
deleteTsion Zewdu Minas; Eboneé Nicole Butler; Samuel Mwakisha Mwamburi; Tiffany H. Dorsey; Deepa Bedi; Windy Dean-Colomb; Christopher A. Loffredo; Stefan Ambs; Clayton Yates
deleteShare
deleteSave
Evaluation of Time to Metastasis After Prostatectomy as a Prognostic Factor in Patients With Metachronous mHSPC: A Secondary Analysis of the SWOG-1216 Phase 3 Trial
deleteProstate
IF2.5
delete2026-10-07
delete0
deleteOAAI
deleteNicolas Sayegh; Yeonjung Jo; Umang Swami; Varun Nandakumar; Georges Gebrael; Zeynep Irem Ozay; Haoran Li; Krishnam Goel; Benjamin L. Maughan; Melissa Plets; Maha H. A. Hussain; Tanya B. Dorff; Primo N. Lara Jr.; Amir Goldkorn; Seth P. Lerner; Neeraj Agarwal
deleteShare
deleteSave
Histological Prostatic Inflammation Is Associated With Storage Lower Urinary Tract Symptoms and Inflammatory/Fibrotic Marker Expression in Benign Prostate Biopsies
deleteProstate
IF2.5
delete2026-09-30
delete0
PREAI
deleteNaoya Okubo; Minoru Kobayashi; Kazuyuki Ishida; Takao Kamai
deleteShare
deleteSave
Prognostic Value of MRI-Derived Apparent Diffusion Coefficient in Intermediate-Risk Prostate Cancer Treated With Definitive Radiotherapy
deleteProstate
IF2.5
delete2026-09-30
delete0
deleteOAAI
deleteCem Onal; Gurcan Erbay; Aysenur Elmali; Birhan Demirhan; Ozan Cem Guler
deleteShare
deleteSave
GenProb-PCSM: A Simplified Weighted Germline Score for Prostate Cancer-Specific Mortality
deleteProstate
IF2.5
delete2026-09-30
delete0
deleteOAAI
deleteJun Wei; Zhuqing Shi; Lucy Lu; John Wang; Julian Xu; Ashley J. Mulford; Huy Tran; Annabelle Ashworth; S. Lilly Zheng; Alan R. Sanders; William B. Issacs; Jun Luo; Brian Helfand; Jim Lu; Jianfeng Xu
deleteShare
deleteSave
Black Race Predicts Poor Compliance and Higher Prostate Cancer Risk in a Multinational Repeat Biopsy Cohort: Secondary Analysis From the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) Clinical Trial
deleteProstate
IF2.5
delete2026-09-30
delete0
PREAI
deleteAlexis R. Freedland; Daniel M. Moriera; Jun Gong; Stephen J. Freedland
deleteShare
deleteSave
Primary BPH Stromal Cell Cultures Exhibit Heightened Androgen-Responsiveness
deleteProstate
IF2.5
delete2026-09-30
delete0
deleteOAAI
deleteWei Chen; Fulu Dong; Mohammad Reza Askarpour; Laura E. Pascal; Rajiv Dhir; Uma Chandran; Bruce L. Jacobs; Donald B. DeFranco; Naoki Yoshimura; Zhou Wang
deleteShare
deleteSave
Defining a Safe Biopsy Deferral Strategy in Patients With Low-Risk or Equivocal MRI Findings Using Prostate-Specific Antigen-Based Metrics
deleteProstate
IF2.5
delete2026-09-30
delete0
PREAI
deleteOmer Tarik Esengur; Stephanie A. Harmon; Emma J. Stevenson; Rikhil D. Makwana; Donald C. Wunsch III; Maria J. Merino; Sandeep Gurram; Peter L. Choyke; Peter A. Pinto; Baris Turkbey
deleteShare
deleteSave
Is a Few Too Many? Alcohol Consumption and Prostate Cancer Upgrading During Active Surveillance
deleteProstate
IF2.5
delete2026-09-30
delete0
PREAI
deleteJack Campbell; Michelle I. Higgins; Zhuo Tony Su; Yuezhou Jing; Mufaddal Mamawala; Patricia K. Landis; Carlos A. Rivera Lopez; Nirmish Singla; Christian P. Pavlovich; Bruce J. Trock
deleteShare
deleteSave
Adult Levels of Testosterone Induce Prostatic Epithelial Hyperplasia During Mouse Prostate Development Through Puberty
deleteProstate
IF2.5
delete2026-09-30
delete0
PREAI
deleteD'Netria Bledsoe; Zhengxin Wang
deleteShare
deleteSave
Natural History of PI-RADS 3 Lesions on Serial Prostate mpMRI
deleteProstate
IF2.5
delete2026-09-30
delete0
deleteOAAI
deleteTomer Bashi; Yanai Rubinstein; Adi Kidron; Ron Marom; Yuval Rand; Meitar Atias; Sophie Barnes; Ibrahim Fahoum; Gal Keren-Paz; Mario Sofer; Ofer Yossepowitch; Snir Dekalo; Avi Beri; Roy Mano
deleteShare
deleteSave
Survival Outcomes by Frailty and Comorbidities in Veterans Treated With Abiraterone and Enzalutamide for Metastatic Castration-Resistant Prostate Cancer
deleteProstate
IF2.5
delete2026-09-30
delete0
deleteOAAI
deleteMeghana Yellanki; Jennifer La; Danne C. Elbers; Nhan V. Do; Channing J. Paller; Nathanael R. Fillmore; Martin W. Schoen
deleteShare
deleteSave
Androgen Receptor-Immune Crosstalk in Metastatic Castration-Resistant Prostate Cancer: From Context-Dependent Remodeling to Biomarker-Guided Translation
deleteProstate
IF2.5
delete2026-09-30
delete0
PREAI
deleteLinjie Li; Ruixi Feng; Bingyang Zha; Shiqi Yang; Ge Wang; Zhijie Jiang; Jingsong Mou; Fei Gao
deleteShare
deleteSave
Real-World Landscape of BRCA Deleterious Alterations in Advanced Prostate Cancer: Insights From a Nationwide Genomic Database
deleteProstate
IF2.5
delete2026-09-30
delete0
PREAI
deleteHideyasu Tsumura; Dai Koguchi; Ken-ichi Tabata; Izuru Shiba; Shuhei Hirano; Masaomi Ikeda; Takefumi Satoh; Keiko Takahashi; Naomi Araki; Akinori Watanabe; Tsutomu Yoshida; Jiichiro Sasaki; Fumio Takada; Kazumasa Matsumoto
deleteShare
deleteSave
Efficacy of a Simplified Diagnostic–Therapeutic Strategy Based on the Prostate–Pelvic Syndrome Theory Versus NIH Conventional Classification‑Based Protocol for Type III Prostatitis: A Randomized Controlled Trial
deleteProstate
IF2.5
delete2026-09-30
delete0
PREAI
deleteXiaoma Zhang; Li Xiao; Lei Zhou; Zhen Zhang; Chen Zhang; Hexi Du
deleteShare
deleteSave